Skip to main content

Advertisement

Log in

Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aims

Acute kidney injury (AKI) remains a frequent complication after cardiac interventions, such as left atrial appendage closure (LAAC), yet limited data are available on the incidence and clinical implication of AKI in this setting. We sought to assess incidence, predictors and relevance of AKI after LAAC.

Methods and results

We retrospectively analyzed 95 LAAC patients in three European centers. AKI was defined according to the Acute Kidney Injury Network (AKIN) classification. The incidence of AKI was 13.7% with mild AKI in 92.3% and AKI stage > II in 7.7%. Total contrast volume was not linked to the occurrence of AKI (AKI: 127 ± 83 vs. no AKI: 109 ± 92 ml, p = 0.41), however increasing contrast volume (CV) to glomerular filtration rate (GFR) ratio (CV/GFR ratio) was associated with an increased risk of AKI (OR, per unit increase: 1.24, 95% CI 0.97–1.58, p = 0.08). ROC-analysis revealed a moderate predictive value of CV/GFR ratio for the prediction of AKI (AUC: 0.67, 95% CI 0.50–0.84, p = 0.05). Furthermore, AKI was associated with significantly increased mortality 6 months and 1 year after LAAC. No significant difference in the incidence of AKI was observed between patients with mere fluoroscopic and additional echocardiographic guidance (16.3% vs. 11.5%, p = 0.56).

Conclusion

Whereas mild AKI is common in patients after LAAC, severe AKI is rare. AKI after LAAC is associated with poor baseline renal function, increased doses of contrast (CV/GFR ratio) and impaired outcome. Future studies will be needed to elaborate the benefit of reducing or avoiding contrast volume regarding this endpoint.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ACP:

Amplatzer Cardiac Plug

AF:

Atrial fibrillation

AKI:

Acute kidney injury

AKIN:

Acute Kidney Injury Network

AUC:

Area under the curve

CHA2DS2-VASC:

CHA2DS2-VASC-Score

CI:

Confidence interval

CV:

Contrast volume

CV/GFR ratio:

Contrast volume to glomerular filtration rate ratio

CKD:

Chronic kidney disease

GFR:

Glomerular filtration rate

HAS-BLED:

HAS-BLED-score

KDIGO:

Kidney disease improving global outcomes

LAAC:

Left atrial appendage closure

LVEF:

Left ventricular ejection fraction

OAC:

Oral anticoagulation

OR:

Odds ratio

PCI:

Percutaneous coronary intervention

ROC:

Receiver operating characteristic

SD:

Standard deviation

TAVR:

Transcatheter aortic valve replacement

TEE:

Transesophageal echocardiography

References

  1. Reddy VY, Holmes D, Doshi SK et al (2011) Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 123:417–424. https://doi.org/10.1161/CIRCULATIONAHA.110.976449

    Article  PubMed  Google Scholar 

  2. Tzikas A, Shakir S, Gafoor S et al (2016) Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11:1170–1179. https://doi.org/10.4244/EIJY15M01

    Article  PubMed  Google Scholar 

  3. Holmes DR, Kar S, Price MJ et al (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12. https://doi.org/10.1016/j.jacc.2014.04.029

    Article  PubMed  Google Scholar 

  4. D’Ancona G, Safak E, Ince H (2019) Left atrial appendage occlusion in patients with atrial fibrillation and high risk of fall: a clinical dilemma or a budgetary issue? Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01476-0

    Article  PubMed  Google Scholar 

  5. Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229. https://doi.org/10.1007/s00392-015-0910-8

    Article  CAS  PubMed  Google Scholar 

  6. Gupta RK, Bang TJ (2010) Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice. Semin Intervent Radiol 27:348–359. https://doi.org/10.1055/s-0030-1267860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375. https://doi.org/10.1016/S0002-9343(97)00150-2

    Article  CAS  PubMed  Google Scholar 

  8. Hatakeyama Y, Horino T, Nagata K et al (2018) Transition from acute kidney injury to chronic kidney disease: a single-centre cohort study. Clin Exp Nephrol. https://doi.org/10.1007/s10157-018-1571-5

    Article  PubMed  Google Scholar 

  9. Kellum J, Lameire N, Aspelin P et al (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138. https://doi.org/10.1038/kisup.2012.7

    Article  Google Scholar 

  10. Nombela-Franco L, Rodés-Cabau J, Cruz-Gonzalez I et al (2018) Incidence, predictors, and prognostic value of acute kidney injury among patients undergoing left atrial appendage closure. JACC Cardiovasc Interv 11:1074–1083. https://doi.org/10.1016/j.jcin.2018.03.022

    Article  PubMed  Google Scholar 

  11. Stähli BE, Gebhard C, Gick M et al (2018) Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function. Clin Res Cardiol 107:259–267. https://doi.org/10.1007/s00392-017-1179-x

    Article  PubMed  Google Scholar 

  12. Kefer J, Tzikas A, Freixa X et al (2016) Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Int J Cardiol 207:335–340. https://doi.org/10.1016/j.ijcard.2016.01.003

    Article  PubMed  Google Scholar 

  13. Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:1–8. https://doi.org/10.1186/cc5713

    Article  Google Scholar 

  14. Levey AS, De Jong PE, Coresh J et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80:17–28. https://doi.org/10.1038/ki.2010.483

    Article  PubMed  Google Scholar 

  15. Gurm HS, Dixon SR, Smith DE et al (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914. https://doi.org/10.1016/j.jacc.2011.05.023

    Article  PubMed  Google Scholar 

  16. Koskinas KC, Shakir S, Fankhauser M et al (2016) Predictors of early (1-Week) outcomes following left atrial appendage closure With Amplatzer devices. JACC Cardiovasc Interv 9:1374–1383. https://doi.org/10.1016/j.jcin.2016.04.019

    Article  PubMed  Google Scholar 

  17. Tzikas A, Holmes DR, Gafoor S et al (2017) Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. Europace 19:4–15. https://doi.org/10.1093/europace/euw141

    Article  PubMed  Google Scholar 

  18. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264. https://doi.org/10.1161/01.CIR.0000016043.87291.33

    Article  PubMed  Google Scholar 

  19. Keaney JJ, Hannon CM, Murray PT (2013) Contrast-induced acute kidney injury: how much contrast is safe? Nephrol Dial Transplant 28:1376–1383. https://doi.org/10.1093/ndt/gfs602

    Article  PubMed  Google Scholar 

  20. Feldkamp T, Luedemann M, Spehlmann ME et al (2018) Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clin Res Cardiol 107:148–157. https://doi.org/10.1007/s00392-017-1166-2

    Article  PubMed  Google Scholar 

  21. Amin AP, Bach RG, Caruso ML et al (2017) Association of variation in contrast volume with acute kidney injury in patients undergoing percutaneous coronary intervention. JAMA Cardiol 2:1007–1012. https://doi.org/10.1001/jamacardio.2017.2156

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tsai TT, Patel UD, Chang TI et al (2014) Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR cath-PCI registry. JACC Cardiovasc Interv 7:1–9. https://doi.org/10.1016/j.jcin.2013.06.016

    Article  PubMed  PubMed Central  Google Scholar 

  23. Celik O, Ozturk D, Akin F et al (2015) Association between contrast media volume-glomerular filtration rate ratio and contrast-induced acute kidney injury after primary percutaneous coronary intervention. Angiology 66:519–524. https://doi.org/10.1177/0003319714542277

    Article  PubMed  Google Scholar 

  24. Sinning JM, Ghanem A, Steinhuser H et al (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:1141–1149. https://doi.org/10.1016/j.jcin.2010.09.009

    Article  PubMed  Google Scholar 

  25. Spieker M, Hellhammer K, Katsianos S et al (2018) Effect of acute kidney injury after percutaneous mitral valve repair on outcome. Am J Cardiol 122:316–322. https://doi.org/10.1016/j.amjcard.2018.03.358

    Article  PubMed  Google Scholar 

  26. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254–261. https://doi.org/10.1038/ki.1995.32

    Article  CAS  PubMed  Google Scholar 

  27. Laskey WK, Jenkins C, Selzer F et al (2007) Volume-to-creatinine clearance ratio. A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 50:584–590. https://doi.org/10.1016/j.jacc.2007.03.058

    Article  CAS  PubMed  Google Scholar 

  28. Park HS, Kim CJ, Yi JE et al (2015) Contrast volume/raw eGFR ratio for predicting contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention for myocardial infarction. CardioRenal Med 5:61–68. https://doi.org/10.1159/000369940

    Article  PubMed  PubMed Central  Google Scholar 

  29. Aminian A, Lempereur M, Ben Yedder M, Dubois P (2018) Real-time fusion of echocardiography and fluoroscopy allowing successful implantation of a WATCHMAN device without contrast injection. EuroIntervention 14:174–175. https://doi.org/10.4244/EIJ-D-17-00398

    Article  PubMed  Google Scholar 

  30. Sedaghat A, Al-Kassou B, Vij V et al (2019) Contrast-free, echocardiography-guided left atrial appendage occlusion (LAAo): a propensity-matched comparison with conventional LAAo using the AMPLATZER™ Amulet™ device. Clin Res Cardiol 108:333–340. https://doi.org/10.1007/s00392-018-1401-5

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

All co-authors contributed fully in terms of the design of the study, the evaluation of data, the actual manuscript preparation, and the revision and approval of the final submitted manuscript. As the corresponding author, Dr. Gloekler confirms that all authors have approved the final text.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steffen Gloekler.

Ethics declarations

Conflict of interest

Alexander Sedaghat has received travel grants from Abbott, Boston Scientific, Medtronic and Edwards Lifesciences. Baravan Al-Kassou has received travel grants from Abbott. Jan Wilko Schrickel has participated in clinical trials conducted by Abbott. Fabian Nietlispach is a consultant to Abbott, Edwards Lifesciences, and Medtronic. Marco Valgimigli reports research grants, advisory board and lectures fees from Abbott; Stephan Windecker received grants to the institution from Abbott, Biotronik, Boston Scientific, Medtronic and Edwards Lifesciences; Bernhard Meier received speaker and proctor fees from Abbott. Georg Nickenig has received speaker honoraria from Abbott. Steffen Gloekler received institutional grants from Abbott and a grant from the Swiss Heart Foundation. The other authors have no conflicts of interest.

Ethical approval

Declaration of Helsinki: The authors state that the study complies with the Declaration of Helsinki. The locally appointed ethics committee has approved the research protocol. Informed consent has been obtained from the subjects.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Table

 3 Clinical characteristics depending on periprocedural imaging modalities (DOCX 16 kb)

Supplemental Table

 4 Multivariate analysis for independent predictive value for 1-year mortalities (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sedaghat, A., Vij, V., Streit, S.R. et al. Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study. Clin Res Cardiol 109, 444–453 (2020). https://doi.org/10.1007/s00392-019-01524-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-019-01524-9

Keywords

Navigation